| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |